Spilled Blood: CSL & Talecris Terminate Their Merger Deal In Face of FTC Lawsuit
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies decide it is not worth the cost and time to battle the FTC in court; the derailed deal may signal tougher times for pharma mergers.